Publications & Works

Publication Network
Articles 31
All (31)
SCI-E, SSCI, AHCI (15)
SCI-E, SSCI, AHCI, ESCI (15)
Scopus (15)
TRDizin (16)
Other Publications (2)

1. Cladribine as an Alternative to Fludarabine in Melphalan and Total Body Irradiation-Based Reduced Intensity Conditioning.

Sahin U., Urlu S. M., Gokmen A., Arslan O., Ozcan M.
Transplantation and cellular therapy , no.1, 2025 (SCI-Expanded, Scopus) identifier

2. Waldenström Makroglobülinemi Tanılı Hastalarda Klinik Özellikler ve Tedavi Sonuçları: Tek Merkez Deneyimi

ÇALIŞ U., YÜKSEL S., YÜKSEL M., TOPÇUOĞLU P., KUZU I., ARSLAN Ö., et al.
Türkiye'de Lösemi Lenfoma Miyelom Araştırmaları , vol.9, 2025 (TRDizin)

3. Periferik T-Hücreli Lenfoma Hastalarının Geriye Dönük Değerlendirmesi: Tek Merkez Gerçek Yaşam Deneyimi

YÜKSEL M., . C. K. D., CENGİZ SEVAL G., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., et al.
Türkiye'de Lösemi Lenfoma Miyelom Araştırmaları , vol.9, 2025 (TRDizin) identifier

4. Akut Miyeloid Lösemi Tanılı Fit Yaşlı Hastalarda Allojeneik Hematopoetik Kök Hücre Nakli: Tek Merkez Deneyimi

SÖNMEZ G. M., YAVUZ G., TOPRAK S. K., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., et al.
Türkiye'de Lösemi Lenfoma Miyelom Araştırmaları , vol.9, 2025 (TRDizin) identifier

5.

URLU S. M., ŞAHİN U., GÖKMEN A., ARSLAN Ö., ÖZCAN M.
Türkiye'de Lösemi Lenfoma Miyelom Araştırmaları , vol.8, no.3, pp.92-97, 2024 (TRDizin) identifier

6.

KOYUN D., ATEŞAĞAOĞLU B., YÜKSEL S., SEVAL G. C., BOZDAĞ S. C., TOPRAK S. K., et al.
Türkiye'de Lösemi Lenfoma Miyelom Araştırmaları , vol.8, no.3, pp.86-91, 2024 (TRDizin) Creative Commons License identifier

7. Lenfoplazmasitik Lenfomada Yeni Nesil Dizileme Yöntemiyle Mutasyon İncelemesinin Tanı ve Tedavi Planında Yeri

KOYUN D., YÜKSEL S., Cengiz Seval G., CİVRİZ BOZDAĞ S., Toprak S. K., Topcuoglu P., et al.
Türkiye'de Lösemi Lenfoma Miyelom Araştırmaları , vol.8, no.1, pp.39-45, 2024 (TRDizin) Creative Commons License identifier

8. Activity of venetoclax in patients with relapsed or refractory chronic lymphocytic leukaemia: analysis of the VENICE-1 multicentre, open-label, single-arm, phase 3b trial

Kater A. P., ARSLAN Ö., Demirkan F., Herishanu Y., Ferhanoglu B., Diaz M. G., et al.
The Lancet Oncology , vol.25, no.4, pp.463-473, 2024 (SCI-Expanded, Scopus) identifier identifier identifier

9. Vitamin D Gene Polymophism in Patients with Aseptic Necrosis after Allogeneic Hematopoietic Stem Cell Transplantation

Soydan E., Sahin U., Ceylaner S., gökmen a., Dogan H., Kurdal Okcu M., et al.
Türkiye'de Lösemi Lenfoma Miyelom Araştırmaları , vol.7, no.2, pp.51-56, 2023 (TRDizin) Creative Commons License identifier

10. Allogeneic Hematopoietic Stem Cell Transplantation for Primary Myelofibrosis: A 20-year Experience in a Single Center

CENGİZ SEVAL G., Civriz Bozdag S., TOPRAK S. K., Kurt Yuksel M., TOPÇUOĞLU P., ARSLAN Ö., et al.
Balkan medical journal , vol.40, no.3, pp.197-204, 2023 (SCI-Expanded, Scopus) Creative Commons License identifier identifier

11. Outcomes of Autologous Stem Cell Transplantation as a Consolidative Strategy for the Treatment of Primary and Isolated Secondary Central Nervous System Diffuse Large B Cell Lymphomas

Sahin U., Gokmen A., Soydan E., Urlu S. M., Merter M., Gokgoz Z., et al.
Clinical Lymphoma, Myeloma and Leukemia , vol.23, 2023 (SCI-Expanded, Scopus) identifier identifier identifier

12. Gemcitabine, Cisplatin, and Dexamethasone as a Salvage and Mobilization Chemotherapy Before Autologous Stem Cell Transplantation is Effective and Safe Outpatient Regimen in Relapsed and Refractory Hodgkin Lymphoma Patients

Gokmen A., Sahin U., Soydan E., Gokgoz Z., Okcu M. K., Ozan U., et al.
Clinical Lymphoma, Myeloma and Leukemia , vol.22, no.10, 2022 (SCI-Expanded, Scopus) identifier identifier identifier

13. Pretransplant Consolidation Therapies Improve the Outcome of Myeloablative Allogeneic Transplantation in Adults with Ph-negative Acute Lymphoblastic Leukemia

Ozdemir Z. N., Kircali E., Şahin U., Seval G., Bozdağ S. C., Toprak S. K., et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , vol.22, no.8, pp.596-600, 2022 (SCI-Expanded, Scopus) Sustainable Development identifier identifier identifier

14. Alpha-1-Antitrypsin Experience for Steroid-Resistant Acute Graft-Versus-Host Disease

KOYUN D., CENGİZ SEVAL G., Kircali E., CİVRİZ BOZDAĞ S., TOPRAK S. K., TOPÇUOĞLU P., et al.
INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION , vol.38, no.3, pp.601-605, 2022 (SCI-Expanded, Scopus) identifier identifier identifier

15. İkinci Allojenik Kök Hücre Nakli: Gerçek Yaşam Verisi

KIRCALI E., CENGİZ SEVAL G., ÖZTÜRK C., YILMAZ H., ŞENOYMAK M. C., YAVUZ G., et al.
Türkiye'de Lösemi Lenfoma Miyelom Araştırmaları , vol.6, no.2, pp.50-55, 2022 (TRDizin) identifier

16. The Influence of ATG on the Outcomes of Patients With AML at the Time of Unrelated Donor Transplantation

CENGİZ SEVAL G., KIRCALI E., CİVRİZ BOZDAĞ S., TOPÇUOĞLU P., YÜKSEL M., DALVA K., et al.
Ankara Üniversitesi Tıp Fakültesi Mecmuası , vol.74, no.3, pp.337-342, 2021 (TRDizin) identifier

17. Relaps Refrakter Hodgkin Lenfomada Brentuksimab Vedotin Kullanımı: Tek Merkez Deneyimi

Koyun D., Cengiz Seval G., Sökmen M., Akkuş E., Atilla E., Civriz Bozdağ S., et al.
Türkiye'de Lösemi Lenfoma Miyelom Araştırmaları , vol.5, no.1, pp.1-4, 2021 (TRDizin) identifier

18. Highlighting the Prognostic Importance of Measurable Residual Disease Among Acute Myeloid Leukemia Risk Factors

Ozdemir Z. N., Sahin U., DALVA K., BALTACI M. A., Uslu A., Ozturk C., et al.
TURKISH JOURNAL OF HEMATOLOGY , vol.38, no.2, pp.111-118, 2021 (SCI-Expanded, Scopus, TRDizin) Creative Commons License identifier identifier identifier identifier

19. Melphalan pharmacokinetics and transplant related toxicity during autologous stem cell transplantation

Sahin U., Soydan E., Gokmen A., ÖZCAN M., ARSLAN Ö.
BONE MARROW TRANSPLANTATION , vol.56, no.1, pp.7-8, 2021 (SCI-Expanded, Scopus) identifier identifier

20. Allojeneik kök hücre naklinde Primer ve sekonder graft yetmezliği

ATİLLA E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPRAK S. K., ARSLAN Ö., et al.
Türkiye'de Lösemi Lenfoma Miyelom Araştırmaları , vol.5, 2021 (TRDizin) identifier

21. The Efficacy of Therapeutic Thrombocytapheresis in Patients with Thrombocytosis

NARLI ÖZDEMİR Z., ŞAHİN U., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPRAK S. K., TOPÇUOĞLU P., et al.
Ankara Üniversitesi Tıp Fakültesi Mecmuası , vol.74, 2021 (TRDizin) identifier

22. Myelodisplastik Sendromda Allojeneik Kök Hücre Nakli

ATACA ATİLLA P., ATİLLA E., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., TOPÇUOĞLU P., et al.
Ankara Üniversitesi Tıp Fakültesi Mecmuası , vol.73, no.2, pp.113-117, 2020 (TRDizin)

23. Safety and Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Mycosis Fungoides and Sezary Syndrome: A 7-year Tertiary Center Analysis

CENGİZ SEVAL G., ATİLLA E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., et al.
Türkiye'de Lösemi Lenfoma Miyelom Araştırmaları , vol.4, no.2, pp.23-27, 2020 (TRDizin)

24. The Impact of Pre-transplant Serum Ferritin on Outcomes of Allogeneic Transplantation for Acute Leukemia

ŞAHİN U., ERDAL H., GÜNDÜZ M., MERTER M., NARLI ÖZDEMİR Z., CİVRİZ BOZDAĞ S., et al.
Türkiye'de Lösemi Lenfoma Miyelom Araştırmaları , vol.3, no.1, pp.9-13, 2019 (Peer-Reviewed Journal)

25. Extracorporeal photochemotherapy in mycosis fungoides

Atilla E., Atilla P. A., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPRAK S. K., Topcuoglu P., et al.
TRANSFUSION CLINIQUE ET BIOLOGIQUE , vol.24, no.4, pp.454-457, 2017 (SCI-Expanded, Scopus) identifier identifier identifier

26. A Randomized Comparison of Hemoglobin Content-Based Versus Standard (Unit-Based) Red Blood Cell Transfusion Policy

ATİLLA E., Toprak S. K., civriz bozdag s., TOPÇUOĞLU P., Arslan Ö.
Turkish Journal of Hematology , vol.34, no.3, pp.244-249, 2017 (SCI-Expanded, Scopus, TRDizin) Creative Commons License identifier identifier identifier identifier

27. Yoğun Kemoterapi Almış RefrakterHematolojik HastalıklardaHaploidentik Kök Hücre NaklininSağkalıma Etkisİ

YÜKSEL M., DALVA K., ŞAHİN U., KURDALOKCU M., KÖKSAL Ö., GÖKMEN A., et al.
LLM DERGİ , 2017 (Peer-Reviewed Journal)

28. Therapeutic plasma exchange in the treatment of neuroimmunologic disorders: review of 50 cases.

Yucesan C., Arslan Ö., Arat M., Yucemen N., Ayyildiz E., Ilhan O., et al.
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis , vol.36, no.1, pp.103-7, 2007 (SCI-Expanded, Scopus) identifier identifier identifier

29. Tuberculosis in stem cell transplant patients

Akan H., Arslan Ö., Akan O.
JOURNAL OF HOSPITAL INFECTION , vol.62, no.4, pp.421-426, 2006 (SCI-Expanded, Scopus) Sustainable Development identifier identifier identifier

30. Electronic crossmatching

Arslan Ö.
TRANSFUSION MEDICINE REVIEWS , vol.20, no.1, pp.75-79, 2006 (SCI-Expanded, Scopus) identifier identifier identifier

31. Haemovigilance in developing countries

Arslan Ö.
HEMATOLOGY , vol.10, pp.79-81, 2005 (SCI-Expanded, Scopus) identifier identifier
Papers Presented at Peer-Reviewed Scientific Conferences 210

1. YOĞUN İNDÜKSİYONA UYGUN AKUT MİYELOİD LÖSEMİ HASTALARINDA HİPOMETİLE EDİCİ İLAÇ-VENETOKLAKS İLE İNDÜKSİYON TEDAVİSİNİN SONUÇLARI

ÇALIŞ U., ŞAHİN U., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., ÖZCAN M., et al.
51.Ulusal Hematoloji kongresi, Turkey, 28 October 2025, (Full Text)

2. İNFÜZE EDİLEN CD34+ VE CD3+ HÜCRE MİKTARININ VE CD34+/CD3+ ORANININ AKHN SONUÇLARINA ETKİLERİ

ŞEN T., KILIÇ Ö., ŞAHİN U., CENGİZ SEVAL G., YÜKSEL M., TOPÇUOĞLU P., et al.
51.Ulusal Hematoloji kongresi, Turkey, 28 October - 02 November 2025, (Full Text)

3. TONSİL NON-HODGKİN LENFOMALARININ KLİNİK ÖZELLİKLERİ, TEDAVİYE YANIT VE PROGNOZUNUN ANALİZİ

YÜKSEL M., YURDAKUL B. E., KÖKCÜ G., BEKTAŞ M., CENGİZ SEVAL G., TOPRAK S. K., et al.
51.Ulusal Hematoloji kongresi, Turkey, 28 October - 02 November 2025, (Full Text)

4. SAÇLI HÜCRELİ LÖSEMİDE KLADRİBİN MONOTERAPİSİNİN UZUN DÖNEM SONUÇLARI VE NÜKSÜ ÖNGÖREN İMMÜNOFENOTİPİK BELİRTEÇLER

BEKTAŞ M., YURDAKUL B. E., DALVA K., ŞAHİN U., CENGİZ SEVAL G., TOPRAK S. K., et al.
51.Ulusal Hematoloji kongresi, Turkey, 28 October - 02 November 2025, (Full Text)

5. ATG KULLANILAN ALLOJENİK KÖK HÜCRE NAKLİNDE DAHA YÜKSEK TRASPLANTASYON ÖNCESİ LENFOSİT SAYISI SAĞKALIM ORANININ İYİLEŞMESİYLE İLİŞKİLİDİR

KÖKCÜ G., DALVA K., YÜKSEL M., TOPRAK S. K., TOPÇUOĞLU P., ARSLAN Ö., et al.
51.Ulusal Hematoloji kongresi, Turkey, 28 October - 02 November 2025, (Full Text)

6. WHO VE ICC IŞIĞINDA MPN’LERİN GENETİK ÖZELLİKLERİ VE KLİNİK KORELASYONU

SÖNMEZ G. M., LEBLEBİCİ C. B., YÜRÜR KUTLAY N., CENGİZ SEVAL G., TOPRAK S. K., TOPÇUOĞLU P., et al.
51.Ulusal Hematoloji kongresi, Turkey, 28 October - 02 November 2025, (Full Text)

7. SPİNAL MANYETİK REZONANS GÖRÜLTÜLEMEDE ANORMAL KEMİK İLİĞİ YOĞUNLUĞUNUN HEMATOLOJİK HASTALIKLARLA İLİŞKİSİ

AYDOĞAN M., CENGİZ SEVAL G., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., ÖZCAN M., et al.
51.Ulusal Hematoloji kongresi, Turkey, 28 October - 02 November 2025, (Full Text)

8. MİKOSİZ FUNGOİDES VE SEZARY SENDROMLU HASTALARDA BRENTUXİMAB VEDOTİN TEDAVİSİNİN UZUN DÖNEM SONUÇLARI

Yüksel M., Şanlı H., Dalva K., Cengiz Seval G., Topçuoğlu P., Arslan Ö., et al.
50.Ulusal Hematoloji Kongresi, Antalya, Turkey, 29 October - 02 November 2024, pp.111, (Full Text)

9. HİPEREOZİNOFİLİK SENDROM ALT TİPLERİNDE TANI VE TEDAVİ: RETROSPEKTİF TEK MERKEZLİ ÇALIŞMA

BEKTAŞ M., ÇİFTÇİ A., TOPRAK S. K., YÜKSEL M., TOPÇUOĞLU P., ÖZCAN M., et al.
50.Ulusal Hematoloji Kongresi, 29 October - 02 November 2024, (Full Text)

10. STEROİD REFRAKTER GRAFT VERSUS HOST HASTALIĞINDA FOTOFEREZ KULLANIMI VE YANITLARININ DEĞERLENDİRİLMESİ, TEK MERKEZ DENEYİMİ

BEKTAŞ M., ÇİFTÇİ A., CENGİZ SEVAL G., TOPRAK S. K., TOPÇUOĞLU P., ÖZCAN M., et al.
50.Ulusal Hematoloji Kongresi, 29 October - 02 November 2024, (Full Text) Creative Commons License

11. MANTLE HÜCRELİ LENFOMA TANILI HASTALARDA İBRUTİNİB KULLANIMI: TEK MERKEZ DENEYİMİ

KÖKCÜ G., CENGİZ SEVAL G., YÜKSEL M., TOPRAK S. K., ARSLAN Ö., ÖZCAN M., et al.
50.Ulusal Hematoloji Kongresi, 29 October - 02 November 2024, (Full Text)

12. NÜKS DİRENÇLİ T HÜCRELİ LENFOMALARDA PRALATREKSAT KULLANIMI: TEK MERKEZ DENEYİMİ

SÖNMEZ G. M., CENGİZ SEVAL G., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., ÖZCAN M., et al.
50.Ulusal Hematoloji Kongresi, 29 October - 02 November 2024, (Full Text) Creative Commons License

13. PAROKSİSMAL NOKTURNAL HEMOGLOBİNÜRİ TANILI HASTALARIN DEĞERLENDİRMESİ, TEK MERKEZLİ ÇALIŞMA

BEKTAŞ M., ÇİFTÇİ A., CENGİZ SEVAL G., YÜKSEL M., TOPÇUOĞLU P., ÖZCAN M., et al.
50.Ulusal Hematoloji Kongresi, 29 October - 02 November 2024, (Full Text)

14. PERİFERİK T HÜCRELİ LENFOMA TANILI HASTALARIN ANALİZİ: TEK MERKEZ DENEYİMİ

YÜKSEL M., DEMİR C. K., CENGİZ SEVAL G., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., et al.
50.Ulusal Hematoloji Kongresi, 29 October 2024, (Full Text)

15. GÜNCEL KLAVUZLAR EŞLİĞİNDE KLİNİKTE MASTOSİTOZ: TEK MERKEZ DENEYİMİ

AYDOĞAN M., CENGİZ SEVAL G., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., ÖZCAN M., et al.
50.Ulusal Hematoloji Kongresi, 29 October - 02 November 2024, (Full Text)

16. Prognostic evaluation of PET/CT in residual post-chemotherapy +/- RT masses in patients with Hodgkin Lymphoma and its impact on survival

BEKTAŞ M., KAR İ., CENGİZ SEVAL G., TOPRAK S. K., TOPÇUOĞLU P., ÖZCAN M., et al.
11TH AEGEAN HEMATOLOGY ONCOLOGY SYMPOSIUM, 19 - 22 September 2024, (Full Text)

17. ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN RELAPS/REFRACTORY LYMPHOMA PATIENTS: A SINGLE CENTER EXPERIENCE

Karakaya B., Yilmaz H., Ermis G. Y., Cengiz Seval G., Bozdag S. C., Toprak S. K., et al.
49th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, ELECTR NETWORK, 23 - 26 April 2023, pp.457-458, (Summary Text) identifier

18. KRONİK LENFOSİTİK LÖSEMİLERDE İMMUNGLOBULİN GENLERİ VARYANT ALT TİPLERİ, ALT KLONLAR İLE SOMATİK HİPERMUTASYON İLE HASTALIK BİYOLOJİSİNİN İLİŞKİSİ

Aygün R. Ş., Yüksel S., Örüncü M. B., Yüksel M., Cengiz Seval G., Arslan Ö., et al.
49. Ulusal Hematoloji Kongresi , Antalya, Turkey, 1 - 05 November 2023, pp.148-149, (Full Text) Creative Commons License

19. ALPHA-1-ANTITRYPSIN EXPERIENCE FOR STEROID-RESISTANT ACUTE GRAFT-VERSUS-HOST DISEASE

Koyun D., Cengiz Seval G., Bozdag S. C., Toprak S. K., Topçuoğlu P., Özcan M., et al.
49th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, ELECTR NETWORK, 23 - 26 April 2023, pp.301-302, (Summary Text) identifier

20. EXTERNAL VALIDATION OF THREE EXISTING EARLY MYELOMA RELAPSE SCORES (BY EBMT, CIBMTR, AND GIMEMA) IN A SINGLE CENTER SHOWS MAJOR DIFFERENCES

Beksaç M., Cengiz Seval G., Civriz Bozdağ S., Toprak S. K., Yüksel M., Topçuoğlu P., et al.
The 49th Annual Meeting of the European Society for Blood and Marrow Transplantation: Physicians, Paris, France, 23 April 2023, vol.58, pp.107, (Full Text)

21. P19 EXTERNAL VALIDATION OF THREE EXISTING EARLY MYELOMA RELAPSE SCORES (BY EBMT, CIBMTR, AND GIMEMA) IN A SINGLE CENTER SHOWS MAJOR DIFFERENCES

BEKSAÇ M., CENGİZ SEVAL G., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., TOPÇUOĞLU P., et al.
The 49th Annual Meeting of the European Society for Blood and Marrow Transplantation, France, 23 April 2023, (Full Text)

22. Single Center Real World Data That Compares Autologous Stem Cell Transplant in the Era of Anti-CD38 Monoclonal Antibody Based Treatments for AL Amyloidosis

Yilmaz H., Cengiz Seval G., Karakaya B., Yavuz G., Aydogan M., Bozdag S. C., et al.
64th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Louisiana, United States Of America, 10 - 13 December 2022, vol.140, pp.4369-4370, (Summary Text) Creative Commons License identifier

23. The Impact of CD34+Cell and Immunefector Cell Dose on Transplant Outcomes

Koyun D., Cengiz Seval G., Bozdag S. C., Toprak S. K., Topçuoğlu P., Özcan M., et al.
64th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Louisiana, United States Of America, 10 - 13 December 2022, vol.140, pp.12673-12674, (Summary Text) Creative Commons License identifier

24. Prophylactic defibrotide is effective for acute graft versus host disease as well as sinusoidal obstructive syndrome

KIRCALİ E., CENGİZ SEVAL G., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., et al.
48th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), United States Of America, 19 - 22 March 2022, (Full Text)

25. GRAFT VERSUS HOST HASTALIĞI PROFİLAKSİSİNDE ATG VE POST CY KULLANIMININ NAKİL SONUÇLARINA ETKİSİ: TEK MERKEZ DENEYİMİ

Karakaya B., ŞAHİN Y. İ., MAMMADLI H., Yavuz G., CENGİZ SEVAL G., CİVRİZ BOZDAĞ S., et al.
14. Ulusal kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, 10 March 2022, (Full Text)

26. THE OUTCOME OF AUTOLOGOUS HEMATOPOIETIC CELL TRANSPLANTATION IN ELDERLY PATIENTS WITH AGGRESSIVE NON-HODGKIN LYPHOMA

İLHAN O., CENGİZ SEVAL G., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., TOPÇUOĞLU P., et al.
63TH ASH CONGRESS, ATLANTA, United States Of America, 8 - 11 December 2021, (Full Text)

27. The Outcome of Autologous Hematopoietic Cell Transplantation in Elderly Patients with Aggressive Non-Hodgkin Lymphoma

İLHAN O., CENGİZ SEVAL G., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., TOPÇUOĞLU P., et al.
63rd ASH Annual Meeting and Exposition, 11 December 2021, (Full Text)

28. HODGKİN LENFOMA TANILI HASTALARDA EKSTRANODAL TUTULUM VE YENİ TEDAVİLER

Yavuz Ermiş G., Yilmaz H., Özütemiz S., Selvi N., Öztürk C., Kırcalı E., et al.
47. Ulusal Hematoloji Kongresi , Antalya, Turkey, 4 - 07 November 2021, pp.346-347, (Full Text)

29. T/B LENFOBLASTİK LENFOMA TANILI HASTALARIN YENİ TEDAVİLER IŞIĞINDA RETROSPEKTİF DEĞERLENDİRİLMESİ

Karakaya B., Akbulut H., Öztürk C., Koyun D., Kırcalı E., Yilmaz H., et al.
47. Ulusal Hematoloji Kongresi , Antalya, Turkey, 4 - 07 November 2021, pp.178-179, (Full Text)

30. AKUT PROMİYELOSİTİK LÖSEMİ TANILI HASTALARIN KLİNİK ÖZELLİKLERİ VE TEDAVİ SONUÇLARI: TEK MERKEZ DENEYİMİ

Yavuz Ermiş G., Yilmaz H., Özütemiz S., Selvi N., Öztürk C., Kırcalı E., et al.
47. Ulusal Hematoloji Kongresi , Antalya, Turkey, 4 - 07 November 2021, pp.202-204, (Full Text)

31. PROFLAKTİK DEFİBROTİD SOS DIŞINDA AKUT GRAFT VS HOST HASTALIĞINDA DA ETKİN

KIRCALI E., CENGİZ SEVAL G., ÖZTÜRK C., YILMAZ H., Yavuz G., Karakaya B., et al.
47. Ulusal Hematoloji Kongresi, 04 November 2021, (Full Text)

32. RELAPS/ REFRAKTER HODGKİN LENFOMA HASTALARINDA ALLOJENİK HEMATOPOETİK KÖK HÜCRE NAKLİ: TEK MERKEZ DENEYİMİ

Koyun D., Şahin U., Cengiz Seval G., Civriz Bozdağ S., Toprak S. K., Yüksel M., et al.
13. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, Antalya, Turkey, 2 - 03 April 2021, no.52, pp.104-105, (Full Text)

33. KAN GRUBU UYUŞUMSUZLUĞUNUN HAPLOİDENTİK TRANSPLANT SONUÇLARINA ETKİSİ VE KAN GRUBU DÖNÜŞÜM SÜRECİ

GÖKGÖZ M., ŞAHİN U., GÖKMEN A., SOYDAN E., CENGİZ SEVAL G., ARSLAN Ö., et al.
13. Ulusal kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, 02 April 2021, (Full Text)

34. ALLOJENİK KÖK HÜCRE NAKLİ HASTALARINDA PERİTRANSPLANT METRONİDAZOL KULLANIMIYLA AKUT GVHD RİSKİNİN İLİŞKİ

KIRCALI E., CENGİZ SEVAL G., ÖZTÜRK C., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., et al.
13. Ulusal kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, 02 April 2021, (Full Text)

35. Relaps/Refrakter Hodgkin Lenfoma Hastalarında Allojenik Hematopoetik Kök Hücre Nakli: Tek Merkez Deneyimi

KOYUN D., ŞAHİN U., SEVAL G. C., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M. K., et al.
13. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, 2 - 03 April 2021, (Full Text)

36. MULTİPL MİYELOMDA OTOLOG PRİFERİK KÖK HÜCRE NAKLİ SONRASI ERKEN NÜKSÜ BELİRLEMEDE CIBMTR, ISS VE R-ISS SKORLAMA SİSTEMLERİNİN KARŞILAŞTIRILMASI

CENGİZ SEVAL G., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., et al.
13. Ulusal kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, 02 April 2021, (Full Text)

37. PATIENT RELATED FACTORS OVERRIDE LENALIDOMIDE MAINTENANCE AS A FACTOR OF SEVERITY FOR COVID-19 INFECTION

KIRCALI E., CENGİZ SEVAL G., TOPRAK S. K., TOPÇUOĞLU P., ARSLAN Ö., ÖZCAN M., et al.
8th International Congress on Leukemia Lymphoma Myeloma, Ankara, Turkey, 21 May 2021, vol.38, pp.50, (Full Text) Sustainable Development

38. THE IMPACT OF PRETRANSPLANT IMMUNOMODULATORY DRUGS ON CMV REACTIVATION

YÜKSEL M., CENGİZ SEVAL G., USLU A., KIRCALI E., KOYUN D., Yavuz G., et al.
8 45 th International Congress on Leukemia Lymphoma Myeloma, Ankara, Turkey, 21 May 2021, vol.38, no.71, pp.1-81, (Full Text)

39. GRAFT VS HOST HASTALIĞINDA ALFA- 1 ANTİTRİPSİN DENEYİMİMİZ

Koyun D., Cengiz Seval G., Kırcalı E., Civriz Bozdağ S., Toprak S. K., Topçuoğlu P., et al.
46. Ulusal Hematoloji Kongresi , Antalya, Turkey, 28 - 31 October 2020, no.283, pp.117-118, (Full Text)

40. MYELOPROLİFERATİF NEOPLAZİDE PEG-IFN-α-2A ETKİNLİK VE GÜVENİLİRLİĞİ: TEK MERKEZ RETROSPEKTİF GERÇEK YAŞAM ÇALIŞMASI

Koyun D., Cengiz Seval G., Civriz Bozdağ S., Toprak S. K., Topçuoğlu P., Arslan Ö., et al.
46. Ulusal Hematoloji Kongresi , Antalya, Turkey, 28 - 31 October 2020, no.197, pp.112, (Full Text)

41. FOLİKÜLER LENFOMADA BAZAL PET’ TE TOPLAM METABOLİK TÜMÖR HACMİ VE TOPLAM LEZYON GLİKOLİZİNİN PROGNOSTİK ÖNEMİ

Kırcalı E., Cengiz Seval G., Araz M., Uslu A., Öztürk C., Koyun D., et al.
46. Ulusal Hematoloji Kongresi, Antalya, Turkey, 28 - 31 October 2020, no.278, pp.105, (Full Text)

42. AKUT MYELOBLASTİK LÖSEMİ HASTALARINDA NÜKLEOFOSMİN MUTASYONU MİNİMAL REZİDÜEL HASTALIK TAKİBİNDE YOL GÖSTERİCİMİDİR

CENGİZ SEVAL G., ÖZCAN M., TOPÇUOĞLU P., DEMİRER T., BEKSAÇ M., CİVRİZ BOZDAĞ S., et al.
42.Ulusal Hematoloji Kongresi, Turkey, 28 - 30 October 2020, (Full Text)

43. CD34+ VE İMMUNEFEKTÖR HÜCRE SAYIMININ TRANSPLANTASYON SONUÇLARINA ETKİSİ

Koyun D., Cengiz Seval G., Dalva K., Uslu A., Öztürk C., Kırcalı E., et al.
12. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, Muğla, Turkey, 5 - 07 March 2020, no.159, pp.60-61, (Full Text)

44. Effect of Cyclophosphamide on Hemorrhagic Cystitis Following Haploidentical Related Compared to Matched Related/Unrelated Donor Hematopoietic Stem Cell Transplantation: A 7-Year Tertiary Center Analysis

SEVAL G. C., Öztürk n., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., et al.
61st ASH Annual Meeting, 7 - 10 December 2019, (Full Text)

45. Effect of Cyclophosphamide on Hemorrhagic Cystitis Following Haploidentical Related Compared to Matched Related/Unrelated Donor Hematopoietic Stem Cell Transplantation: A 7-Year Tertiary Center Analysis

CENGİZ SEVAL G., Ozturk N., CİVRİZ BOZDAĞ S., Yuksel M. K., TOPÇUOĞLU P., ARSLAN Ö., et al.
61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Florida, United States Of America, 7 - 10 December 2019, vol.134, (Summary Text) identifier identifier

46. Which One, Generic Vs Original Glivec Is More Effective in Patients with Chronic Myeloid Leukemia?

Kircali E., CENGİZ SEVAL G., CİVRİZ BOZDAĞ S., TOPRAK S. K., Yuksel M. K., ARSLAN Ö., et al.
61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Florida, United States Of America, 7 - 10 December 2019, vol.134, (Summary Text) identifier

47. Large Granular Lymphocytosis and Its Impact on Long Term Clinical Outcomes Following Allogeneic Hematopoietic Stem Cell Transplantation: 14-Year Follow-up Data

CENGİZ SEVAL G., Uslu A., Kircali E., CİVRİZ BOZDAĞ S., DALVA K., TOPRAK S. K., et al.
61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Florida, United States Of America, 7 - 10 December 2019, vol.134, (Summary Text) identifier identifier

48. HANGİSİ, ORJİNAL İMATİNİB Mİ JENERİK Mİ KRONİK MYELOİD LÖSEMİDE DAHA ETKİN?

KIRCALI E., CENGİZ SEVAL G., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., ARSLAN Ö., et al.
45. Ulusal Hematoloji Kongresi, 31 October 2019, (Full Text)

49. IMID/PI İÇEREN TEDAVİLERE DİRENÇLİ MM OLGULARINDA POM/LEN İLE BİRLİKTE ELOTUZUMAB TEDAVİSİ KALICI ≥ÇİKY SAĞLAYABİLİR Mİ?

BEKSAÇ M., CENGİZ SEVAL G., PAYDAŞ S., FIRATLI TUĞLULAR T., ARSLAN Ö., GÖKER H., et al.
45. Ulusal Hematoloji Kongresi, Antalya, Turkey, 30 October 2019, pp.168, (Full Text)

50. Elotuzumab Plus Pomalidomide or Lenalidomide is Able to Achieve Durable = Vgpr Responses Among Immunomodulatory/Proteasome Inhibitor Refractory Myeloma Patients: A Report on Multicenter Experience From Turkey

BEKSAÇ M., CENGİZ SEVAL G., PAYDAŞ S., TUĞLULAR A. T., ARSLAN Ö., GÖKER A. H., et al.
17th International Myeloma Workshop, 12 - 15 September 2019, (Summary Text)

51. Is mobilization with chemotherapy effect response in the multiple myeloma?

CENGİZ SEVAL G., Uslu A., CİVRİZ BOZDAĞ S., YÜKSEL M., ARSLAN Ö., ÖZCAN M., et al.
45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Frankfurt, Germany, 24 - 27 March 2019, vol.54, pp.500, (Summary Text) identifier

52. Blood group incompatibility in haplo-identical stem cell transplantation: Favor or unfavorable effect on the erythrocyte recovery?

CENGİZ SEVAL G., Uslu A., TOPRAK S. K., CİVRİZ BOZDAĞ S., YÜKSEL M., ARSLAN Ö., et al.
45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Frankfurt, Germany, 24 - 27 March 2019, vol.54, pp.368-369, (Summary Text) identifier

53. Can the drugs used before autologous hematopoietic stem cell transplantation have impact on CMV reactivation that results in decreased os in myeloma patients after ASCT?

YÜKSEL M., CENGİZ SEVAL G., Uslu A., Kircili E., KOYUN D., Ozturk C., et al.
45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Frankfurt, Germany, 24 - 27 March 2019, vol.54, pp.505-506, (Summary Text) identifier

54. Haploidentical stem cell transplantation may be an option for hematological malignancies in urgent conditions

İLHAN O., CENGİZ SEVAL G., Uslu A., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., et al.
45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Frankfurt, Germany, 24 - 27 March 2019, vol.54, pp.382, (Summary Text) identifier

55. Can Nelarabıne Rescue The Graft After Allogeneıc Hematopoıetıc Stem Cell Transplantatıon In T-All ?

YÜKSEL M., CENGİZ SEVAL G., CİVRİZ BOZDAĞ S., TOPRAK S. K., TOPÇUOĞLU P., ARSLAN Ö., et al.
24 Congress of the European Hematology Association, 13 - 16 June 2019, (Summary Text)

56. CAN THE DRUGS USED BEFORE AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION (ASCT) HAVE IMPACT ON CMV REACTIVATION THAT RESULTS IN DECREASED OS IN MYELOMA PATIENTS AFTER ASCT?

Yüksel M., Cengiz Seval G., Uslu A., Kırcalı E., Koyun D., Öztürk C., et al.
7th International Congress on Leukemia Lymphoma Myeloma, İstanbul, Turkey, 2 - 04 May 2019, pp.59, (Full Text)

57. CAN AUTOLOGOUS STEM CELL TRANSPLANTATION ABROGATE THE POOR PROGNOSIS ASSOCIATED WITH HIGH LDH?

Cengiz Seval G., Civriz Bozdağ S., Yüksel M., Topçuoğlu P., Arslan Ö., Özcan M., et al.
7th International Congress on Leukemia Lymphoma Myeloma, İstanbul, Turkey, 2 - 04 May 2019, pp.45, (Full Text)

58. HAPLOIDENTICAL STEM CELL TRANSPLANTATION MAY BE A GOOD ALTERNATIVE AS SALVAGE TREATMENT FOR HEAVILY PRETREATED PATIENTS WITH LEUKEMIA

Cengiz Seval G., Uslu A., Civriz Bozdağ S., Toprak S. K., Yüksel M., Topçuoğlu P., et al.
7th International Congress on Leukemia Lymphoma Myeloma, İstanbul, Turkey, 2 - 04 May 2019, pp.56-57, (Full Text)

59. COMPARISION OF AUTOLOGOUS CONDITIONING REGIMENS AMONG LYMPHOMA PATIENTS

Gokgöz Z., Uğur Bilgin A., Arslan Ö., Özcan M., İlhan O.
7th International Congress on Leukemia Lymphoma Myeloma, İstanbul, Turkey, 2 - 04 May 2019, pp.52, (Full Text)

60. LEUKAPHERESIS REDUCES 4-WEEK MORTALITY IN ACUTE MYELOID LEUKEMIA PATIENTS WITH HYPERLEUKOCYTOSIS - A RETROSPECTIVE STUDY FROM A TERTIARY CENTER

Cengiz Seval G., Uslu A., Civriz Bozdağ S., Toprak S. K., Yüksel M., Topçuoğlu P., et al.
7th International Congress on Leukemia Lymphoma Myeloma, İstanbul, Turkey, 2 - 04 May 2019, pp.37, (Full Text)

61. SUCCESSFUL TREATMENT OF GRAFT FAILURE WITH SECOND ALLOGENEIC STEM CELL TRANSPLANTATION WITHOUT CONDITIONING REGIMEN

Cengiz Seval G., Uslu A., Öztürk C., Civriz Bozdağ S., Yüksel M., Topçuoğlu P., et al.
8th International Congress on Leukemia Lymphoma Myeloma, İstanbul, Turkey, 2 - 04 May 2019, pp.75, (Full Text)

62. IS AGE AN IMPORTANT FACTOR FOR AUTOLOGOUS PERIPHERAL HEMATOPOIETIC STEM CELL TRANSPLANTATION IN ELDERLY PATIENTS WITH NONHODGKIN LYMPHOMA?

Cengiz Seval G., Uslu A., Civriz Bozdağ S., Toprak S. K., Yüksel M., Topçuoğlu P., et al.
7th International Congress on Leukemia Lymphoma Myeloma, İstanbul, Turkey, 2 - 04 May 2019, pp.47-48, (Full Text)

63. Pretransplant hemoglobin and serum creatinine levels correlate with progression free survival in myeloma patients undergoing autologous stem cell transplantation.

DEMİRER T., CENGİZ SEVAL G., TOPRAK S. K., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., et al.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 31 May - 04 June 2019, vol.37, (Summary Text) identifier

64. retrospective analysis of 149 unselected patıents wıth mantle cell lymphoma confırms prognostic relevance of mıpı: sıngle center ecperıence

CENGİZ SEVAL G., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., ÖZCAN M., et al.
ICLLM 2019, 02 May 2019, (Full Text)

65. CAN AUTOLOGOUS STEM CELL TRANSPLANTATIONABROGATE THE POOR PROGNOSIS ASSOCIATED WITH HIGHLDH?

SEVAL G. C., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., ÖZCAN M., et al.
7th International Congress on Leukemia Lymphoma Myeloma, 2 - 04 May 2019, (Full Text)

66. HEV seroprevalence in blood donors in Turkey: Comparison of two commercial anti-HEV total Ab ELISA kit

Yasar O., Cengiz G., Karatayli E., Kizilpinar M., Yurdcu E., ALBAYRAK DELİALİOĞLU R., et al.
International Liver Congress / 54th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), Vienna, Austria, 10 - 14 April 2019, vol.70, (Summary Text) identifier

67. MULTİPLE MYELOM HASTALARINDA OTOLOG PERİFERİK KÖK HÜCRE NAKLİ ESNASINDA GELİŞEN NÖTROPENİK ATEŞ

Uslu A., Cengiz Seval G., Öztürk C., Narlı Özdemir Z., Kırcalı E., Koyun D., et al.
11. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, Antalya, Turkey, 1 - 02 March 2019, no.142, pp.130, (Full Text)

68. Transplant Sonrası Trombositopenide Eltrombopag: Tek Merkez Deneyimimiz

Kırcali E., Cengiz Seval G., Koyun D., Civriz Bozdağ S., Topçuoğlu P., Özcan M., et al.
11. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, Antalya, Turkey, 1 - 03 March 2019, (Full Text)

69. Does Level of Vitamin D Prior to Allogeneic Stem Cell Transplantation Affect the Transplant Outcomes?

Soydan E., Gokmen A., Gokgoz Z., Sen S., Ozkumur K. O., Okcu M. K., et al.
Transplant and Cell Therapy Meeting / Combined Annual Meetings of the American-Society-for-Blood-and-Marrow-Transplantation (ASBMT) and the Center-for-International-Blood-and-Marrow-Transplant-Research (CIBMTR), Texas, United States Of America, 13 - 24 February 2019, vol.25, (Summary Text) identifier

70. HAPLOİDENTİK KÖK HÜCRE NAKİLLERİNDE KAN GRUBU UYUMSUZLUĞU: ERİTROSİT ENGRAFTMANI ÜZERİNE ETKİSİ VAR MI?

CENGİZ SEVAL G., USLU A., TOPRAK S. K., CİVRİZ BOZDAĞ S., YÜKSEL M., ARSLAN Ö., et al.
11. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, 01 March 2019, (Full Text)

71. Influence of Conditioning Regimens with Total Body Irradiation (TBI) on Graft Versus Host Disease and Graft Versus Leukemia Effect Following Donor Lymphocyte Infusions (DLI)

CENGİZ SEVAL G., Atilla E., Ulas B., CİVRİZ BOZDAĞ S., TOPRAK S. K., Yuksel M. K., et al.
Transplant and Cell Therapy Meeting / Combined Annual Meetings of the American-Society-for-Blood-and-Marrow-Transplantation (ASBMT) and the Center-for-International-Blood-and-Marrow-Transplant-Research (CIBMTR), Texas, United States Of America, 13 - 24 February 2019, vol.25, (Summary Text) identifier

72. Comparision of Outcomes According to HLA Disparity in Acute Leukemia Patients: A Single Cente Institution Experience

TOPÇUOĞLU P., CENGİZ SEVAL G., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., DALVA K., et al.
60th ASH Annual Meeting and Exposition, 01 December 2018, (Full Text)

73. Impact of ABO Mismatch on Outcomes of Allogeneic Hematopoietic Stem Cell Recipients: 30 Years of Experience with 1016 Patients

Atilla E., TOPÇUOĞLU P., AKKUŞ E., Atilla P. A., CİVRİZ BOZDAĞ S., YÜKSEL M., et al.
60th Annual Meeting of the American-Society-of-Hematology (ASH), California, United States Of America, 1 - 04 December 2018, vol.132, (Summary Text) identifier identifier

74. Donor Lymphocyte Infusions for Relapsed Hematological Malignancies after Allogeneic Hematopoietic Stem Cell Transplantation: Single Center Experience

GÜRMAN G., CENGİZ SEVAL G., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., TOPÇUOĞLU P., et al.
60th Annual Meeting of the American-Society-of-Hematology (ASH), California, United States Of America, 1 - 04 December 2018, vol.132, (Summary Text) identifier

75. Retrospective Analysis of 149 Unselected Patients with Mantle Cell Lymphoma Confirms Prognostic Relevance of Mantle Cell Lymphoma International Prognostic Index: Single Center Experience

CENGİZ SEVAL G., Ulas B., TAŞCI O., Ozel F., Bulat B., KUZU I., et al.
60th Annual Meeting of the American-Society-of-Hematology (ASH), California, United States Of America, 1 - 04 December 2018, vol.132, (Summary Text) identifier

76. Akut Miyeloid Lösemide Nakil Öncesi ve Nakil Sonrası +28. Gün Değerlendirilen Minimal Kalıntı Hastalığın Hastalık Seyrine Etkisi

DALVA K., NARLI ÖZDEMİR Z., ŞAHİN U., USLU A., MURADOVA B., CENGİZ SEVAL G., et al.
44. Ulusal Hematoloji Kongresi, Antalya, Turkey, 31 October - 03 November 2018, pp.245-246, (Summary Text)

77. ALLOJENİK HEMATOPOİETİK KÖK HÜCRE NAKLİ YAPILAN ALL HASTALARINDA CMV ENFEKSİYONUNUN NAKİL SONUÇLARINA ETKİLERİ

KALACI E., ŞAHİN EROĞLU D., CENGİZ SEVAL G., NARLI ÖZDEMİR Z., BEKSAÇ M., ÖZCAN M., et al.
44. Ulusal Hematoloji Kongresi, Turkey, 31 October - 03 November 2018, (Full Text)

78. ALLOJENİK HEMATOPOİETİK KÖK HÜCRE NAKLİ YAPILANALL HASTALARINDA CMV ENFEKSİYONUNUN NAKİLSONUÇLARINA ETKİLERİ

KALACI E., ŞAHİN EROĞLU D., CENGİZ SEVAL G., NARLI ÖZDEMİR Z., BEKSAÇ M., ÖZCAN M., et al.
44. Ulusal Hematoloji Kongresi, Turkey, 31 October - 03 November 2018, (Summary Text)

79. AKUT LÖSEMİ HASTALARINDA HLA UYUŞUMSUZLUĞUNUNNAKİL SONUÇLARINA ETKİSİ: TEK MERKEZ DENEYİMİ

CENGİZ SEVAL G., NARLI ÖZDEMİR Z., TATAR L., SÖKMEN M., CİVRİZ BOZDAĞ S., TOPRAK S. K., et al.
44. Ulusal Hematoloji Kongresi, Turkey, 31 October - 03 November 2018, (Summary Text)

80. Comparing Conditioning Regimens for Autologous Stem Cell Transplantation in Lymphoma Patients

CENGİZ SEVAL G., GÖREN ŞAHİN D., SOYDAN E., ÖZÇELİK E. T., GÖKMEN A., GÖKGÖZ Z., et al.
2018 Society of Hematologic Oncology (SOHO) Annual Conference, 12 - 15 September 2018, (Full Text)

81. Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation with Different Doses of Antithymocyte Globulin Containing Conditioning in Hematological Malignancies

Gokgoz Z., Soydan E., Gokmen A., ARSLAN Ö., İLHAN O., ÖZCAN M.
44th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Lisbon, Portugal, 18 - 21 March 2018, vol.53, pp.284-285, (Summary Text) identifier

82. Haploidentical transplantation does not have survival advantage over unrelated donor transplantation in haematological diseases

Soydan E., Gokmen A., Gokgoz Z., İLHAN O., ARSLAN Ö., ÖZCAN M.
44th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Lisbon, Portugal, 18 - 21 March 2018, vol.53, pp.747, (Summary Text) identifier

83. Is post-transplant albumin a predictor of early transplant complications?

TOPÇUOĞLU P., CENGİZ SEVAL G., AKKUŞ E., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., et al.
44th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Lisbon, Portugal, 18 - 21 March 2018, vol.53, pp.344-345, (Summary Text) identifier

84. BCNU-EAM vs non-BCNU alternative alkylator -EAM conditioning regimens for autologous stem cell transplantation in lymphoma patients

Sahin D. G., Cengiz G. S., Soydan E., Ozcelik E. T., Gokmen A., Gokgoz Z., et al.
44th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Lisbon, Portugal, 18 - 21 March 2018, vol.53, pp.256-257, (Summary Text) identifier

85. Age is Not an Important Factor for Autologous Peripheral Hematopoietic Stem Cell Mobilization and Collection in Patients with Multiple Myeloma

İLHAN O., CENGİZ SEVAL G., TOPRAK S. K., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., et al.
Blood and Marrow Transplantion Tandem Meetings of the Center-for-International-Blood-and-Marrow-Transplant-Research (CIBMTR) / American-Society-for-Blood-and-Marrow-Transplantation (ASBMT), Utah, United States Of America, 21 - 25 February 2018, vol.24, (Summary Text) identifier

86. MYELOFİBROZİSTE ALLOJENEİK HEMATOPOETİK KÖK HÜCRE NAKLİ SONUÇLARI: TEK MERKEZ DENEYİMİ

CENGİZ SEVAL G., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., et al.
10. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, 01 March 2018, (Full Text)

87. Mesenchymal Stem Cell Infusion in Haploidentical Hematopoietic Stem Cell Transplantation in Patients with Hematological Malignancies

Arslan Ö., Elçin A. E., Atilla E., Seker Ş., Baydın P., Gunduz M., et al.
Blood and Marrow Transplantion Tandem Meetings of the Center-for-International-Blood-and-Marrow-Transplant-Research (CIBMTR) / American-Society-for-Blood-and-Marrow-Transplantation (ASBMT), Utah, United States Of America, 21 - 25 February 2018, vol.24, (Summary Text) identifier

88. AKUT GRAFT VERSUS HOST HASTALIĞI KLİNİK SONUÇLARI: TEK MERKEZ DENEYİMİ

NARLI ÖZDEMİR Z., CENGİZ SEVAL G., USLU A., ÖZTÜRK C., CİVRİZ BOZDAĞ S., TOPRAK S. K., et al.
10. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, Antalya, Turkey, 01 March 2018, (Summary Text)

89. KEMOTERAPİ İLE MOBİLİZASYON MULTİPL MİYELOMDA YANITLARI ETKİLİYOR MU?

CENGİZ SEVAL G., USLU A., CİVRİZ BOZDAĞ S., YÜKSEL M., ARSLAN Ö., ÖZCAN M., et al.
10. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, 01 March 2018, (Full Text)

90. Retrospective Analysis Learn Conditioning for Autologous Stem Cell Transplantation

Soydan E., Gokmen A., Gokgoz Z., İLHAN O., ARSLAN Ö., ÖZCAN M.
Blood and Marrow Transplantion Tandem Meetings of the Center-for-International-Blood-and-Marrow-Transplant-Research (CIBMTR) / American-Society-for-Blood-and-Marrow-Transplantation (ASBMT), Utah, United States Of America, 21 - 25 February 2018, vol.24, (Summary Text) identifier

91. Age Is Not Important for Autologous Peripheral Hematopoietic Stem Cell Transplantation in Multiple Myeloma

Ilhan O., CENGİZ SEVAL G., TOPRAK S. K., Topcuoglu P., Ozel F., CİVRİZ BOZDAĞ S., et al.
59th Annual Meeting of the American-Society-of-Hematology (ASH), Georgia, United States Of America, 9 - 12 December 2017, vol.130, (Summary Text) identifier

92. Dilemma-High Response Rates Vs High Toxicity: Autologous Stem Cell Transplantation for Lymphoma

Atilla E., TOPRAK S. K., CİVRİZ BOZDAĞ S., YÜKSEL M., Topcuoglu P., Akan H., et al.
59th Annual Meeting of the American-Society-of-Hematology (ASH), Georgia, United States Of America, 9 - 12 December 2017, vol.130, (Summary Text) identifier

93. Kronik Myeloproliferatif Neoplazilerde Kalretikulin (CALR) mutasyonu

Öztekin Ş., ÖCAL E., Boyacıgil Ş., ÖZCAN M., BEKSAÇ M., ARSLAN Ö., et al.
Ulusal Hematoloji Kongresi, Turkey, 31 October - 04 November 2017, (Summary Text)

94. Old gene new phenotype: ADA2 deficiency

KOSTEL BAL S., SAHİN U., JIMENEZ HEREDİA R., ROMANO F., KAYGUSUZ G., AZZARI C., et al.
ESID 2017, 11 - 14 September 2017, (Summary Text)

95. ALLOEGENEİC HEMATOPOİETİC STEM CELL TRANSPLANTATİON İN ADVANCED AGE ADULTS:İS İT POSSİBLE TO TRANSPLANT SAFELY?

ATİLLA E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPRAK S. K., AKAN H., et al.
ebmt2017, 26 - 29 March 2017, (Summary Text)

96. A biosimilar G-CSF filgrastim is as effective as refrence drug however it is not as cost effective as it supposed to be and by the way no imapct on health care system.

YÜKSEL M., PEKCAN G., ŞAHİN U., CİVRİZ BOZDAĞ S., TOPRAK S. K., TOPÇUOĞLU P., et al.
43rd Annual Meeting of the European Society for Blood and Marrow Transplantation, Marseille, France, 26 - 29 March 2017, (Summary Text)

97. The outcome of haploidentical stem cell transplantation

ATİLLA E., bilgiç e., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPRAK S. K., TOPÇUOĞLU P., et al.
ebmt 2017, 22 - 25 June 2017, (Summary Text)

98. REAL WORLD DATA IN RELAPSED REFRACTORY MYELOMA PATIENTS TREATED WITH CARFILZOMIB, A MULTICENTER EXPERİENCE

SEVİNDİK Ö. G., SOLMAZ Ş. M., PEHLİVAN M., KABUKLU S. H., YALNIZ F. F., ÖZKOCAMAN V., et al.
6.INTERNATIONAL CONGRESS OF LEUKEMIA LYMPHOMA MYELOMA, Antalya, Turkey, 11 - 13 May 2017, (Full Text)

99. Isolation And Culture Of Good Manufacturing Practice Grade Human Bone Marrow Derived Mesenchymal Stem Cells For Clinical Applications

ELÇİN A. E., Şeker Ş., BAYDIN P., DALVA K., PARMAKSIZ M., LALEGÜL Ö., et al.
22nd International Symposium on Biomedical Science & Engineering BIOMED, Ankara, Turkey, 12 May 2017, (Summary Text)

100. Real-world data in relapsed refractory myeloma patients with carfilzomib, a multicenter turkish experience

SEVİNDİK Ö. G., medeni solmaz ş., PEHLİVAN M., HACIOĞLU S., YALNIZ F. F., ÖZKOCAMAN V., et al.
6th International Congress on Leukemia-Lymphoma-Myeloma, 11 - 13 May 2017, (Summary Text)

101. A single center experience with two decades of follow-up on patients with hairy cell leukemia.

İLHAN O., Atilla E., Atilla P. A., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPRAK S. K., et al.
53rd Annual Clinical Science Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Symposium on Old Targets, New Drugs - Her2 and MET, Illinois, United States Of America, 2 - 07 June 2017, vol.35, (Summary Text) identifier

102. Eski gen yeni fenotip: Ada2 eksikliği

KÖSTEL BAL S., DOĞU E. F., SAHİN S., KUZU I., BOZTUG K., ARSLAN Ö., et al.
3. klinik immünoloji kongresi, Turkey, 12 - 15 April 2017, (Summary Text)

103. Peripheral blood stem cell mobilization and collection from elderly patients (265 years) with multiple myeloma: A single center experience

CENGİZ SEVAL G., TOPRAK S. K., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., et al.
43rd Annual Meeting of the European Society for Blood and Marrow Transplantation, 26 March 2017, (Full Text)

104. Peripheral Blood Stem Cell Mobilization and collection from elderly patients 65 years with multipl myeloma: A , single center exprience

CENGİZ SEVAL G., TOPRAK S. K., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., et al.
43rd Annual Meeting Of EBMT, 26 - 29 March 2017, (Summary Text)

105. The outcome of Haploidentical Hematopoietic Celll Trnasplantations (Haplo HSCT)

ATİLLA E., ECE B., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPRAK S. K., TOPÇUOĞLU P., et al.
43rd Annual Meeting Of EBMT, 26 - 29 March 2017, (Summary Text)

106. A Biosimiliar G-CSF filgrastim is as effective as a reference drug however it is not cost effective as supposed to be and by the way no impact on the health care system

YÜKSEL M., PEKCAN G., ŞAHİN U., CİVRİZ BOZDAĞ S., TOPRAK S. K., TOPÇUOĞLU P., et al.
43rdAnnual Meeting of the European Society for Blood and Marrow Transplantation, 26 March - 29 December 2017, (Summary Text)

107. İmkomplet Antikorlar ABO çapraz karşılaştırma uyumsuzluğunu azaltabilirler. Bir başlangıç çalışması

ÖZEN M., ÖZKAN T., YILMAZ S., ÖZER Y., SUNGUROĞLU A., GÜRMAN G., et al.
X. Ulusal Kan Merkezleri ve Transfüzyon Tıbbı Kongresi, Antalya, Turkey, 12 - 16 March 2017, (Summary Text)

108. Management and Outcome of Central Nerve System(CNS) Involvement in Acute Lymphoblastic Leukemia

ATİLLA E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., TOPRAK S. K., TOPÇUOĞLU P., ARSLAN Ö., et al.
BMT Tandem Meetings, orlando, United States Of America, 22 - 26 February 2017, vol.23, pp.251, (Summary Text)

109. Catheter Thrombosis in Allogeneic Hematopoietic Stem Cell Transplantation (Allo-HSCT) Recipients

GÜRMAN G., ATİLLA E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPRAK S. K., et al.
BMT Tandem Meetings, 22 - 26 February 2017, (Summary Text)

110. Allogeneic stem cell transplantation for chonic lymphocytic Leukemai

ATİLLA E., ATACA ATİLLA P., pekcan g., İLHAN O., GÜRMAN G., ÖZCAN M., et al.
BMT TANDEM MEETINGS, 22 - 26 February 2017, (Summary Text)

111. Management and Outcome of Central Nervous System (CNS) Involvement in Acute Lymphoblastic Leukemia (ALL)

ATİLLA E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., TOPRAK S. K., TOPÇUOĞLU P., ARSLAN Ö., et al.
BMT Tandem Meetings, 22 - 26 February 2017, (Summary Text)

112. Comparison of Reduced Intensity Conditioning (RIC) Regimen and Myeloablative Conditioning (MAC) Regimen in Allogeneic Hematopoietic Stem Cell Transplantation (Allo-HSCT) for Adult Patients with Acute Leukemia

GÜRMAN G., Guloksuz G. A., Atilla E., Atilla P. A., CİVRİZ BOZDAĞ S., YÜKSEL M., et al.
58th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), California, United States Of America, 3 - 06 December 2016, vol.128, (Summary Text) identifier

113. Does Hypogammaglobulinemia at Diagosis Effects Survival and Infection Risk in Chronic Lymphocytic Leukemia (CLL)?

Atilla E., Atilla P. A., CİVRİZ BOZDAĞ S., TOPRAK S. K., TOPÇUOĞLU P., İLHAN O., et al.
58th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), California, United States Of America, 3 - 06 December 2016, vol.128, (Summary Text) identifier

114. AKUT LENFOSİTİK LÖSEMİDE ALL SANTRAL SİNİRSİSTEMİ SSS TUTULUMUNA YAKLAŞIM

ATİLLA E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., TOPRAK S. K., TOPÇUOĞLU P., ARSLAN Ö., et al.
42.Ulusal Hematoloji Kongresi, Turkey, 19 - 22 October 2016

115. Kronik LenfositikLösemi de Tanı Anında HipogamaglobulinemiSağkalım ve Enfeksiyon Riski Üzerinde Etkili Midir

ATİLLA E., ATACA ATİLLA P., TOPRAK S. K., AKAN H., BEKSAÇ M., İLHAN O., et al.
ULUSAL HEMATOLOJİ 2016, Turkey, 18 - 22 October 2016, (Summary Text)

116. AkutLenfositikLösemide ALL SantralSinirSistemi SSS TutulumunaYaklaşım

ATACA ATİLLA P., ATİLLA E., CİVRİZ BOZDAĞ S., TOPRAK S. K., TOPÇUOĞLU P., ARSLAN Ö., et al.
ULUSAL HEMATOLOJİ 2016, Turkey, 18 - 22 October 2016, (Summary Text)

117. AKUT MYELOİD LÖSEMİDE FLOW SİTOMETRİ İLEİNDÜKSİYON SONRASI TESPİT EDİLEN CD34 HÜCRESAYISI SAĞKALIM VE RELAPSI ETKİLER

ATİLLA E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., TOPRAK S. K., et al.
42. Ulusal Hematoloji Kongresi, Turkey, 19 - 22 October 2016

118. SeyrekbirMalignite Primer Mediastinal Büyük B

ATACA ATİLLA P., ATİLLA E., CENGİZ SEVAL G., PEKCAN G., İLHAN O., ARSLAN Ö., et al.
ULUSAL HEMATOLOJİ 2016, Turkey, 18 - 22 October 2016

119. KRONİK LENFOSİTİK LÖSEMİ DE TANI ANINDAHİPOGAMAGLOBULİNEMİ SAĞKALIM VE ENFEKSİYONRİSKİ ÜZERİNDE ETKİLİ MİDİR

ATACA ATİLLA P., ATİLLA E., PEKCAN G., TOPRAK S. K., TOPÇUOĞLU P., AKAN H., et al.
42. Ulusal Hematoloji Kongresi, Turkey, 19 - 22 October 2016

120. SEYREK BİR MALİGNİTE: PRİMER MEDİASTİNALBÜYÜK B HÜCRELİ LENFOMA

ATACA ATİLLA P., ATİLLA E., CENGİZ SEVAL G., PEKCAN G., İLHAN O., ARSLAN Ö., et al.
42.Ulusal Hematoloji Kongresi, Turkey, 18 - 22 October 2016, (Summary Text)

121. BEING OVERWEIGHT PRIOR TO ALLOGENEIC STEM CELL TRANSPLANTATION IS RELATED TO BETTER SURVIVAL

ATİLLA E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., AKAN H., et al.
JSH 2016, 13 - 15 October 2016, (Summary Text)

122. MANAGEMENT AND OUTCOME OF CENTRAL NERVOUS SYSTEM CNS INVOLVEMENT IN ACUTE LYMPHOBLASTIC LEUKEMIA ALL PRE AND POST TRANSPLANT Conference 21st Congress of the European Hematology AssociationLocation Copenhagen DENMARK

ATACA ATİLLA P., ATİLLA E., CİVRİZ BOZDAĞ S., TOPRAK S. K., TOPÇUOĞLU P., ARSLAN Ö., et al.
21st Congress of the European-Hematology-AssociationLocation: Copenhagen, DENMARK, 9 - 12 June 2016, vol.101

123. Approach to Hairy Cell Leukemia HCL 31 years of Experience

KIRCALI E., ATACA ATİLLA P., ATİLLA E., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., et al.
EHA 2016, 9 - 12 June 2016, (Summary Text)

124. Age as a dicision factor for doing autuologous stem cell transplantation in fit patients with myeloma and lymphoma ASCO Annual Meeting J Clin Oncol 34 2016 suppl abstr e 19001

İLHAN O., ATİLLA E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., et al.
ASCO, 3 - 07 June 2016

125. Age as a decision factor for doing autologous stem cell transplantation in fit patients with myeloma and lymphoma Subcategory

İLHAN O., ATİLLA E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., et al.
ASCO 2016, ABD, 3 - 07 June 2016, (Summary Text)

126. Age as a decision factor for doing autuologous stem cell transplantation in fit patients with myeloma and lymphoma

İLHAN O., ATİLLA E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., et al.
2016 ASCO Annual Meeting., 3 - 07 June 2016, (Summary Text)

127. Age is not a Significant Factor in Decision of Doing Autologous Stem Cell Transplantation in Fit Patients with Myeloma and Lymphoma!

ATİLLA E., ATACA ATİLLA P., TOPRAK S. K., YÜKSEL M., TOPÇUOĞLU P., ÖZCAN M., et al.
ASCO 2016, 3 - 07 June 2016, (Summary Text)

128. THE EFFICACY OF TYROSINE KINASE INHIBITORS WITH STEROID IN Ph ACUTE LYMPHOBLASTIC LEUKEMIA

GÜRMAN G., MERTER M., ATİLLA E., ŞAHİN U., TOPÇUOĞLU P., ARSLAN Ö., et al.
ASCO 2016, ABD, 3 - 07 June 2016, (Summary Text)

129. Are Age and JAK2V617F Mutation Related to Trombosis in Chronic Myeloproliferative Diseases

ATİLLA E., ATACA ATİLLA P., TOPRAK S. K., KAYGUSUZ G., KUZU I., CİVRİZ BOZDAĞ S., et al.
24th Biennial International Congress on Thrombosis, 4 - 07 May 2016, (Summary Text)

130. A rare manifestation: Primary mediastinal large-b cell lymphoma.

Atilla E., Ataca P., İLHAN O., ARSLAN Ö., GÜRMAN G., ÖZCAN M.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 3 - 07 June 2016, vol.34, (Summary Text) identifier

131. Poliradikülopati Bulguları ile Nüks Olan Bir ALL Olgusu

ERDOĞAN S., AKSUN Z., hüseynova s., ARSLAN Ö., ŞENER H. Ö.
32. Ulusal Klinik Nörofizyoloji EEG-EMG Kongresi, Turkey, 27 April - 01 May 2016

132. The efficacy of tyrosine kinase inhibitors with steroid in phi- acute lymphoblastic leukemia.

GÜRMAN G., Merter M., Atilla E., Sahin U., TOPÇUOĞLU P., ARSLAN Ö., et al.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 3 - 07 June 2016, vol.34, (Summary Text) identifier

133. Thrombosis in Paroxysmal Nocturnal Hemoglobinuria Patients: Single Center Experience

MERTER M., ŞAHİN U., GÜNDÜZ M., NARLI ÖZDEMİR Z., CİVRİZ BOZDAĞ S., TOPRAK S. K., et al.
24th Biennial International Congress on Thrombosis, İstanbul, Turkey, 1 - 07 May 2016, vol.141, pp.72, (Summary Text) identifier

134. Poliradikülopati Bulguları İle Nüks Olan Bir ALL Olgusu

Erdoğan S., Özaydın Aksun Z., Hüseynova S., Arslan Ö., Şener H. Ö.
32. Ulusal Klinik Nörofizyoloji EEG-EMG Kongresi, Muğla, Turkey, 27 April - 01 May 2016, pp.66, (Summary Text)

135. Age as a dicision factor for doing autuologous stem cell transplantation in fit patients with myeloma and lymphoma

İLHAN O., ATİLLA E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., TOPRAK S. K., TOPÇUOĞLU P., et al.
ASCO, 3 - 07 June 2016, (Summary Text)

136. 42nd Annual Meeting of the European Society for Blood and Marrow Transplantation

TOPÇUOĞLU P., ATİLLA E., CİVRİZ BOZDAĞ S., YÜKSEL M., ARSLAN Ö., BEKSAÇ M., et al.
42nd Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, 3 - 06 April 2016, (Summary Text)

137. prognosis of acute leukemia patients in active disease undergoing allogeneic hematopoietic stem cell transplantation

ŞAHİN U., MERTER M., ateşağoğlu b., erdal h., CİVRİZ BOZDAĞ S., TOPRAK S. K., et al.
41.ebmt meeting, 22 - 25 March 2015

138. HAİRY CELL LÖSEMİ HCL VAKALARIMIZ TEKMERKEZ DENEYİMİ

Kırcalı E., ATACA P., ATİLLA E., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., et al.
41.Ulusal Hematoloji Kongresi, Turkey, 21 - 24 October 2015

139. DONÖR KAN HEMOGLOBİN SEVİYESİ ÖLÇÜMÜ İÇİNKULLANILAN İKİ YÖNTEMİN KARŞILAŞTIRILMASI

Özdemir Z. N., ATACA P., Özer Y., ARSLAN Ö., TOPÇUOĞLU P.
41.Ulusal Hematoloji Kongresi, Turkey, 21 - 24 October 2015

140. Clinical Allogeneic Transplantation Acute and Chronic GVHD Immune Reconstitution

GÜRMAN G., ATACA P., ATİLLA E., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., et al.
57th ASH Annual Meeting & Exposition, 5 - 08 December 2015

141. Is Initial CD3+T Cell Dose in Donor Lymphocyte Infusion for Relapsed Hematological Malignancies a Prognostic Determinant?

Atilla E., Ataca P., TOPRAK S. K., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., et al.
57th Annual Meeting of the American-Society-of-Hematology, Florida, United States Of America, 5 - 08 December 2015, vol.126, (Summary Text) identifier

142. Positive Impact of Chronic Graft-Versus Host Disease on Survival in 928 Allogeneic Hematopoietic Stem Cell Transplant Recipients

GÜRMAN G., Ataca P., Atilla E., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., et al.
57th Annual Meeting of the American-Society-of-Hematology, Florida, United States Of America, 5 - 08 December 2015, vol.126, (Summary Text) identifier

143. Comparison of Two Different Doses of Corticosteroid Premedication for Antithymocyte Globulin in Allogeneic Hematopoietic Stem Cell Transplantation

Merter M., Atilla E., Sahin U., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., et al.
57th Annual Meeting of the American-Society-of-Hematology, Florida, United States Of America, 5 - 08 December 2015, vol.126, (Summary Text) identifier

144. Allojeneik Hematopoietik Kök Hücre Nakli AHKHN Hastalarında Gelişen Üst ve Alt Solunum Yolları Viral Enfeksiyonları

ATİLLA E., ATACA P., ŞAHİN D., DOLAPÇI G. İ., TEKELİ F. A., CİVRİZ BOZDAĞ S., et al.
Febril Nötropeni Simpozyumu, Turkey, 28 - 30 November 2015, (Summary Text)

145. Hairy Cell Lösemi HCL vakalarımız Tek Merkez Deneyimi

KIRCALI E., ATACA P., ATİLLA E., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., et al.
41. Ulusal Hematoloji Kongresi, Turkey, 21 - 24 October 2015

146. Ph Negatif ALL Hastalarında Allojenik Kök Hücre Nakli Öncesi Tedavilerin Klinik Seyir ile İlişkisi

NARLI ÖZDEMİR Z., EKİN K., ATACA P., ATİLLA E., TOPÇUOĞLU P., CİVRİZ BOZDAĞ S., et al.
41. Ulusal Hematoloji Kongresi, Turkey, 21 - 24 October 2015

147. Kronik Lenfositik Lösemide Allojeneik Kök Hücre Nakli Deneyimi

PEKCAN G., ATİLLA E., ATACA P., ARSLAN Ö.
41. Ulusal Hematoloji Kongresi, Turkey, 21 - 24 October 2015

148. allojeneik hematopoietik kök hücre naklinde iki farklı antitimosit globulin premedikasyon protokolünün karşılaştırılması

MERTER M., ATİLLA E., ŞAHİN U., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., et al.
ulusal hematoloji kongresi 2015, Turkey, 21 - 24 October 2015

149. allojeneik hematopoietik kök hücre nakli yapılan hastalarda anti HLA antikorları ile engrafman yetmezliği ilişkisi tek merkez deneyimi

MERTER M., ŞAHİN U., ataşağaoğlu b., TUTKAK H., TOPRAK S. K., YÜKSEL M., et al.
41. Ulusal Hematoloji Kongresi, Turkey, 21 - 24 October 2015, (Summary Text)

150. Waldenström Makroglobulinemisinde Tek Merkez Deneyimi

ŞAHİN U., MERTER M., ATİLLA E., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPRAK S. K., et al.
41. Ulusal Hematoloji Kongresi, Antalya, Turkey, 21 - 24 October 2015, pp.106-107, (Summary Text)

151. ALLOJENEİK HEMATOPOİETİK KÖK HÜCRENAKLİNDE İKİ FARKLI ANTİTİMOSİTGLOBULİN PREMEDİKASYON PROTOKOLÜNÜNKARŞILAŞTIRILMASI

MERTER M., ŞAHİN U., Ateşağaoğlu B., TOPRAK S. K., YÜKSEL M., TOPÇUOĞLU P., et al.
41.Ulusal Hematoloji Kongresi, Turkey, 21 - 24 October 2015

152. Allojeneik Hematopoietik Kök Hücre Nakli Yapılan Hastalarda Anti HLA Antikorları ile Engrafman Yetmezliği İlişkisi: Tek Merkez Deneyimi

MERTER M., ŞAHİN U., ATEŞAĞAOĞLU B., TUTKAK H., TOPRAK S. K., YÜKSEL M., et al.
41. Ulusal Hematoloji Kongresi, Antalya, Turkey, 21 - 24 October 2015, (Summary Text)

153. MYELODİSPLASTİK SENDROMDA MDS ALLOJENEİKHEMATOPOİETİK KÖK HÜCRE NAKLİ

ATİLLA E., ATACA P., BEKSAÇ M., ÖZCAN M., ARSLAN Ö., İLHAN O., et al.
41.Ulusal Hematoloji Kongresi, Turkey, 21 - 24 October 2015

154. Allojeneik Hematopoietik Kök Hücre Naklinde İki Farklı Antitimosit Globulin Premedikasyon Protokolünün Karşılaştırılması

MERTER M., ATİLLA E., ŞAHİN U., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., et al.
41. Ulusal Hematoloji Kongresi, Antalya, Turkey, 21 - 24 October 2015, pp.71-72, (Summary Text)

155. ALLOJENEİK KÖK HÜCRE TRANSPLANTASYONHASTASINDA KRONİK GRAFT VERSUS HOSTHASTALIĞININ GENEL SAĞKALIM ÜZERİNE ETKİSİ

ATİLLA E., ATACA P., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., DEMİRER T., et al.
41. Ulusal Hematoloji Kongresi, Turkey, 21 - 24 October 2015

156. ALLOJENEİK HEMATOPOİETİK KÖK HÜCRE NAKLİ YAPILAN HASTALARDA ANTİ HLA ANTİKORLARI İLE ENGRAFMAN YETMEZLİĞİ İLİŞKİSİ TEK MERKEZ DENEYİMİ

MERTER M., ŞAHİN U., ateşağaoğlu b., TOPRAK S. K., YÜKSEL M., TOPÇUOĞLU P., et al.
41.Ulusal Hematoloji Kongresi, Turkey, 21 - 23 October 2015, (Summary Text)

157. 928 ALLOJENEİK KÖK HÜCRE TRANSPLANTASYONHASTASINDA KRONİK GRAFT VERSUS HOSTHASTALIĞININ GENEL SAĞKALIM ÜZERİNE ETKİSİ

ATİLLA E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., DEMİRER T., et al.
41. Ulusal Hematoloji Kongresi, Turkey, 21 - 24 October 2015, (Summary Text)

158. Chronic Myeloproliferative Disease in Geriatric Patients Single Center Experience

TOPRAK S. K., ATİLLA E., ATACA P., BEKSAÇ M., konuk n., TOPÇUOĞLU P., et al.
77th Annual Meeting of the Japanese Society of Hematology, 16 - 18 October 2015

159. Is Allogeneic Stem Cell Transplantation Safe in MDS

TOPÇUOĞLU P., ATİLLA E., ATACA P., BEKSAÇ M., ÖZCAN M., ARSLAN Ö., et al.
77th Annual Meeting of Japanese Society of Hematology, 16 - 18 October 2015

160. Myeloproliferative Disease in Geriatric Patients Single Center Experience

TOPRAK S. K., ATİLLA E., ATACA P., BEKSAÇ M., Konuk N., TOPÇUOĞLU P., et al.
77th Annual Meeting of the Japanese Society of Hematology, 16 - 19 October 2015

161. Allogeneic Stem Cell Transplant Safe in MDS

TOPÇUOĞLU P., ATİLLA E., ATACA P., BEKSAÇ M., ÖZCAN M., ARSLAN Ö., et al.
77th Annual Meeting of the Japanese Society of Hematology, October 16-18, 2015, Kanazawa, Japan., 1 - 03 October 2015, (Summary Text)

162. Is Allogeneic Stem Cell Transplant Safe in MDS

TOPÇUOĞLU P., ATİLLA E., ATACA P., BEKSAÇ M., ÖZCAN M., ARSLAN Ö., et al.
77th Annual Meeting of the Japanese Society of Hematology, Oral Presentation, 16 - 18 October 2015

163. CML leukemic stem cell CML LCS Its existence in patients who achieved cytogenetic molecular response under treatment of TKI

İLHAN O., USLU A., TOPRAK S. K., TOPÇUOĞLU P., ATİLLA E., ATACA P., et al.
ASCO 2015, 29 - 02 May 2015

164. Azatitidine in combination with ATRA valproic acid in elderly AML patient

ÖZCAN M., CİVRİZ BOZDAĞ S., BERNA A., ATİLLA E., ATACA P., TOPRAK S. K., et al.
ASCO 2015, 29 May - 02 June 2015

165. Extramedullary Relapse of Acute Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation Allo HSCT A Single Center Experience 41st Annual Meeting of the European Society for Blood and

MERTER M., uğur ş., gündüz m., ATİLLA E., CİVRİZ BOZDAĞ S., TOPRAK S. K., et al.
(Allo-HSCT): A Single Center Experience. 41st Annual Meeting of the European Society for Blood and Marrow Transplantation, Istanbul, 22-25 Mayıs 2015., 22 - 25 May 2015, (Full Text)

166. Allogeneic Stem Cell Transplantation for Hodgkin and non Hodgkin Lymphoma

ATACA P., ATİLLA E., CİVRİZ BOZDAĞ S., TOPRAK S. K., TOPÇUOĞLU P., ARSLAN Ö., et al.
5th International Congress on Lymphoma Leukemia Myeloma, İstanbul, Turkey, 21-23 May 2015. Turkish Society of Hematology, Proceedings & Abstract Book, abstract # 0109, poster # PS-101 pp 175., 21 - 23 May 2015

167. AUTOLOGOUS STEM CELL TRANSPLANTATION IN ELDERLY PATIENTS 60 YEARS WITH MYELOMA OR LYMPHOMA

ATİLLA E., GÜNDÜZ M., ATACA P., CİVRİZ BOZDAĞ S., TOPRAK S. K., MELTEM K. Y., et al.
5th International Congress on Lymphoma Leukemia Myeloma, İstanbul, Turkey, 21 - 23 May 2015, (Summary Text)

168. Azacitidine in combination with ATRA, valproic acid in elderly AML patients.

ÖZCAN M., CİVRİZ BOZDAĞ S., Atesagaoglu B., Atilla E., Ataca P., TOPRAK S. K., et al.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, United States Of America, 29 May - 02 June 2015, vol.33, (Summary Text) identifier

169. Does chronic lymphocytic leukemia occur in younger adults in Turkey?

Pekcan G., Atilla E., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., TOPÇUOĞLU P., et al.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, United States Of America, 29 May - 02 June 2015, vol.33, (Summary Text) identifier

170. Autologous Stem Cell Transplantation in Elderly Patients with Myeloma or Lymphoma

ATİLLA E., MEHMET G., ATACA P., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., et al.
Best of ASBMT Tandem Meetings, Poster Presentation, Turkey, 27 - 28 March 2015

171. Autologus stem cell transplantation in elderly patients with myeloma and lymphoma single center experience

GÜNDÜZ M., ATİLLA E., ATACA P., PEKCAN G., CİVRİZ BOZDAĞ S., TOPRAK S. K., et al.
41.EBMT KONGRESİ, 24 - 26 March 2015

172. THE RELAPSE IN ACUTE LEUKEMIA AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION NO APPROACHES HAVE BEEN SUPERIOR YET

TOPÇUOĞLU P., GÜNDÜZ M., ÖZEN M., ATİLLA E., ATACA P., CİVRİZ BOZDAĞ S., et al.
41.EBMT MEETING, 24 - 26 March 2015

173. ALOGENEİC STEM CELL TRANSPLANTATION IN ADULT PATIENTS WITHPAROXYSMAL NOCTURNAL HEMOGLOBINURIA SINGLE CENTER EXPERIENCE

MERTER M., ŞAHİN U., ATİLLA E., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., et al.
41.EBMT MEETING, 24 - 26 March 2015

174. EXTRAMEDULLARY RELAPSE OF ACUTE LEUKEMIA AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION A SINGLE CENTER EXPERIENCE

MERTER M., ŞAHİN U., GÜNDÜZ M., ATİLLA E., CİVRİZ BOZDAĞ S., TOPRAK S. K., et al.
41.EBMT MEETING, 24 - 26 March 2015

175. ımpact pf pretransplant serum ferritinon outcomes of allogeenic hematopoeitic stem cell transplantationfor acute leukemia

ŞAHİN U., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., et al.
41.ebmt meeting, 22 - 25 March 2015

176. Different Doses of Anti Thymocyte Globulin ATG in the Conditioning Regimen for Allogeneic Hematopoetic Stem Cell Transplantation 22 25 March 2015 Bone Marrow Transplant 2015 50 S1 S228

GÜLTEKİN P., ATEŞAĞAOĞLU B., MERTER M., TOPÇUOĞLU P., CİVRİZ BOZDAĞ S., TOPRAK S. K., et al.
41st Annual Meeting of the European Society for Blood and Marrow Transplantation Istanbul, Turkey, 22 - 25 March 2015, (Summary Text)

177. Prognosis of Acute Leukemia Patients with Active Disease Undergoing Allogeneic Hematopoietic Stem Cell Transplantation Allo HSCT 22 25 March 2015 Bone Marrow Transplant 2015 50 S1 S483

UĞUR Ş., MERTER M., ATAŞAĞAOĞLU B., ERDAL H., CİVRİZ BOZDAĞ S., TOPRAK S. K., et al.
41st Annual Meeting of the European Society for Blood and Marrow Transplantation Istanbul, Turkey, 22 - 25 March 2015, (Summary Text)

178. s it possible to overcome the catastrophic complications of Hematopoietic Stem Cell Transplantation HSCT using Plasma Exchange PE A Single Center s Experience

YÜKSEL M., Gultekin G., Edipoglu E., Bay M., CİVRİZ BOZDAĞ S., TOPRAK S. K., et al.
41st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, 22 - 25 March 2015, (Summary Text)

179. Upper and Lower Respiratory Tract Infections by Respiratory Viruses by Respiratory Viruses in Adult Recipients of Allogeneic Hematopoietic Stem Cell Transplantation Single Center Experience

ŞAHİN D., ATİLLA E., CİVRİZ BOZDAĞ S., ATACA P., TOPRAK S. K., TOPÇUOĞLU P., et al.
41th EBMT Meeting, 22 - 25 March 2015, (Summary Text)

180. Chronic Myeloproliferative Disease in Geriatric Patients

TOPRAK S. K., ATİLLA E., ATACA P., BEKSAÇ M., konuk n., TOPÇUOĞLU P., et al.
77th Annual Meeting of the Japanese Society of Hematolog, 16 - 18 October 2015, (Full Text)

181. Do FMS-like Tyrosine Kinase 3 and Nucleophospmin 1 Gene Mutations Really Effect Survival in Acute Myeloid Leukemia ?

Gunduz M., Ataca P., Ozen M., Atilla E., CİVRİZ BOZDAĞ S., TOPRAK S. K., et al.
56th Annual Meeting of the American-Society-of-Hematology, San-Francisco, Costa Rica, 6 - 09 December 2014, vol.124, (Summary Text) identifier

182. Clinical Reflection of Immunophenotyping in Paroxysmal Nocturnal Hemoglobinuria: Experience of a Single Center

Sahin U., Merter M., Ataca P., Atilla E., Atesagaoglu B., Pekcan G., et al.
56th Annual Meeting of the American-Society-of-Hematology, San-Francisco, Costa Rica, 6 - 09 December 2014, vol.124, (Summary Text) identifier

183. Haploidentical Stem Cell Transplantation (SCT) Using Flamsa Regimen As Salvage Chemotherapy

YÜKSEL M., Gokmen A., ÖZCAN M., ARSLAN Ö., İLHAN O., Ozbek D., et al.
56th Annual Meeting of the American-Society-of-Hematology, San-Francisco, Costa Rica, 6 - 09 December 2014, vol.124, (Summary Text) identifier

184. Treatment Approaches in Acute Leukemia Patients Relapsing Following Allogeneic Hematopoietic Stem Cell Transplantation

TOPÇUOĞLU P., Gunduz M., Ozen M., CİVRİZ BOZDAĞ S., TOPRAK S. K., ARSLAN Ö., et al.
56th Annual Meeting of the American-Society-of-Hematology, San-Francisco, Costa Rica, 6 - 09 December 2014, vol.124, (Summary Text) identifier

185. Fertility in Our Allogeneic Hematopoietic Stem Cell Transplant Patients

TOPÇUOĞLU P., Ataca P., CİVRİZ BOZDAĞ S., TOPRAK S. K., ARSLAN Ö., ÖZCAN M., et al.
56th Annual Meeting of the American-Society-of-Hematology, San-Francisco, Costa Rica, 6 - 09 December 2014, vol.124, (Summary Text) identifier

186. Is R-CODOX-M/IVAC Inferior to Other Regimens in Burkitt's Lymphoma: A Single Center Experience

Atilla E., Sahin U., Ataca P., Uslu A., Kircali E., Atesagaoglu B., et al.
56th Annual Meeting of the American-Society-of-Hematology, San-Francisco, Costa Rica, 6 - 09 December 2014, vol.124, (Summary Text) identifier

187. Favorable Treatment Alternative for Primary Central Nervous System Lymphoma: Combined Chemotherapy Regimen Consisting of High-Dose Methotrexate, Rituximab and Cytosine-Arabinoside

Ataca P., TOPRAK S. K., Atilla E., TOPÇUOĞLU P., YÜKSEL M., KAYGUSUZ G., et al.
56th Annual Meeting of the American-Society-of-Hematology, San-Francisco, Costa Rica, 6 - 09 December 2014, vol.124, (Summary Text) identifier

188. Is the Chronic Myeloproliferative Disease Prognosis Really Different in Geriatric Patients?

İLHAN O., Ataca P., Atilla E., TOPRAK S. K., KAYGUSUZ G., KUZU I., et al.
56th Annual Meeting of the American-Society-of-Hematology, San-Francisco, Costa Rica, 6 - 09 December 2014, vol.124, (Summary Text) identifier

189. STEM CELL MOBILIZASTION IN ELDERLY MULTIPLE MYELOMA PATIENTS: SINGLE CENTER EXPERIENCE

TOPRAK S. K., CENGİZ SEVAL G., AYYILDIZ E., TOPÇUOĞLU P., ARSLAN Ö., ÖZCAN M., et al.
19th Congress of the European Hematology Association, 12 June 2014, (Full Text)

190. İnşaat sırasında meydana gelebilecek hematolojik infeksiyonların engellenmesi

ÖZEN M., YILMAZ G., ÇOŞKUN B., TOPÇUOĞLU P., ÖZTÜRK B., GÜNDÜZ M., et al.
İnfeksiyon dünyası çalıştayı, Turkey, 20 February - 23 March 2014, (Summary Text)

191. Refrakter Akut Lösemide FLAMSA tedavsinin ardından T hücresinden arındırılmamış Haploidentik Allojeneik Kök Hücre Transplantasyonu

YÜKSEL M., gökmen a., tek i., özbek d., kurdal okçu m., köktaş ö., et al.
8.Ulusal Kemik İliği Transplantasyonu ve Kök Hücre Tedavileri Kongresi, Turkey, 6 - 08 March 2014, (Summary Text)

192. AKRABA DIŞI ALLOJENEİK HEMATOPOETİK HÜCRE NAKLİNDE HLA UYUŞUMUNUN ETKİSİ-TEK MERKEZ DENEYİMİ

CENGİZ SEVAL G., TOPÇUOĞLU P., ÖZEN M., GÜNDÜZ M., ATİLLA E., DALVA K., et al.
8. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, 06 March 2014, (Summary Text)

193. Hazırlama rejimi ile ilişkili çok nadir bir komplikasyon Akut Yaygın Damar içi Pıhtılaşması

YÜKSEL M., gökmen a., tek i., özbek ., kurdal okçu m., köktaş ö., et al.
8.Ulusal Kemik İliği Transplantasyonu ve Kök Hücre Tedavileri Kongresi, Turkey, 6 - 08 March 2014

194. Management of Hemorrhagic Cystitis after Allogeneic Hematopoietic Stem Cell Transplantation

GÜRMAN G., Atilla E., Ozen M., Kubilay P., Yilmaz G., Gunduz M., et al.
BMT Tandem Meetings, Texas, United States Of America, 26 February - 02 March 2014, vol.20, (Summary Text) Creative Commons License identifier

195. Comparison Of Flow Cytometric and Clinical Findings In Patients With Paroxysmal Nocturnal Hemoglobinuria

Demirer T., Baslar S., Uysal V. A., Beksac M., Ozen M., Konuk N., et al.
55th Annual Meeting of the American-Society-of-Hematology, Louisiana, United States Of America, 7 - 10 December 2013, vol.122, (Summary Text) identifier

196. Paroksismal Noktürnal Hemoglobinüride İmmünfenotipleme Çalışmalarının Kliniğe Yansıması: Tek Merkez Deneyimi

ŞAHİN U., MERTER M., ATACA P., ATİLLA E., ATEŞAĞAOĞLU B., PEKCAN G., et al.
40. Ulusal Hematoloji Kongresi, Antalya, Turkey, 22 - 25 October 2013, pp.131, (Summary Text)

197. Comparison of allogeneic stem cell transplantations in chronic myeloid leukemia before and after the era of tyrosine kinase inhibitors.

Ozcan M., Ozturk B., Ozen M., Topcuoglu P., Arat M., Arslan O., et al.
49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 31 May - 04 June 2013, vol.31, (Summary Text) identifier

198. A randomized comparison of hemoglobin content-based vs standart (unit-based) RBC transfusion policy efficiencies

ATİLLA E., TOPÇUOĞLU P., Yavaşoğlu S., Karakaya A., Geçntürk Ç., CİVRİZ BOZDAĞ S., et al.
Transfusion, 5 - 07 November 2011, (Full Text)

199. HBsAg POZİTİF OLAN ALICILARDA ALLOJENİK HEMATOPOETİK HÜCRE TRANSPLANTASYONU

TOPÇUOĞLU P., SOYDAN E., İDİLMAN R., CENGİZ SEVAL G., ÜSTÜN C., ARSLAN Ö., et al.
35. Ulusal Hematoloji Kongresi, 07 October 2009, (Full Text)

200. Flow Cytometric Analysis of T Cell Functions in CML Patients Under Imatinib Therapy.

Sahin D. G., DALVA K., Meric S., GÜRMAN G., ÖZCAN M., ARSLAN Ö., et al.
50th Annual Meeting of the American-Society-of-Hematology, San-Francisco, Costa Rica, 6 - 09 December 2008, vol.112, pp.911, (Summary Text) identifier

201. Amplitude of response, early mobilization (M) and pre-autologous transplant (ASCT) use of bortezomib (V) and/or thalidomide (T) are predictors of longer progression free (PFS) and/or overall survival (OS) in myeloma

BEKSAÇ M., Soydan E., ÖZKOCAMAN V., TOPÇUOĞLU P., Evranos B., Kizil M., et al.
49th Annual Meeting of the American-Society-of-Hematology, Georgia, United States Of America, 8 - 11 December 2007, vol.110, (Summary Text) identifier

202. The impact of histopathological subtype of cutaneous chronic GvHD on alloHSCT outcome: lichenoid versus scleradermoid

SOYDAN E., CENGİZ SEVAL G., ŞANLI H., TOPÇUOĞLU P., UĞUR BİLGİN A., BAKANAY ÖZTÜRK Ş. M., et al.
33nd Annual Meeting of the European Society for Blood and Marrow Transplantation, 25 March 2007, (Full Text)

203. Refrakter ve Relaps Akut Myeloblastik Lösemide EMA Kurtarma Rejimi Sonuçlarımız

TOPÇUOĞLU P., CİVRİZ BOZDAĞ S., YÜKSEL M., ARSLAN Ö., GÜRMAN G., DEMİRER T., et al.
XXXII. Ulusal Hematoloji Kongresi, Turkey, 8 - 10 November 2006

204. MULTİPL MİYELOMA VE MALİN LENFOMALI HASTALARDA OTOLOG PERİFERİK KÖK HÜCRE TOPLANMASINDA AFEREZ GÜN SAYISI ÖNGÖRÜLEBİLİR Mİ? - ANKARA HESAPLAMA FORMÜLÜ

ARAT M., CENGİZ SEVAL G., SOYDAN E., AYYILDIZ E., TOPÇUOĞLU P., ARSLAN Ö., et al.
32. Ulusal Hematoloji Kongresi, 08 November 2006, (Full Text)

205. Impact of harvest product volume in erythrocyte depletion of allogeneic or autologous bone marrow using COBE spectra

SOYDAN e., AYYILDIZ E., DALVA K., TOPÇUOĞLU P., TOL M., ARSLAN Ö., et al.
15th Congress of the Interdisciplinary-European-Society-for-Haemapheresis-and-Haemotherapy, 5 - 09 October 2005, (Summary Text)

206. Dirençli bacak iskemisi olan Buerger hastalarında otolog kemik iliği mononukleer hücre implantasyonu

DURDU M. S., AKAR A. R., Eren N. T., KAHRAMAN D., ARAT M., ARSLAN Ö., et al.
8. Türk Kalp ve Damar Cerrahisi Ulusal Kongresi, Nevşehir, Turkey, 1 - 05 September 2004, vol.12, pp.130, (Summary Text)

207. The effects of acute normovolemic haemodilution with gelofusine on tissue oxygenation haemodynamic parameters and coagulation

NALAN Ş., ALKIŞ N., ARSLAN Ö., ÇAKAR TURHAN K. S., TÜZÜNER F.
Euroanaesthesia 2004, Lizbon, Portugal, 5 - 08 June 2004

208. Primer Miyelodysplastik Sendrom Tanısı Alan 86 Hastanın Bournemouth Skorlama Sistemine Göre Retrospektif Analizi Ve Toplam Sağkalımı

YÜKSEL M., İLHAN O., TOPÇUOĞLU P., soydan e., BEKSAÇ M., ÖZCAN M., et al.
XXX. Ulusal Hematoloji Kongresi, Turkey, 10 - 12 October 2003

209. Multiple Miyelom MM olgularında Kök Hücre Desteğinde Yüksek Doz Kemoterapinin Konvansiyonel Tedavilerle Karşılaştırıldığında Yaşam Süresini Uzattığına Dair Ankara Tıp Fakültesi Hematoloji Bilim Dalı Deneyimi

BEKSAÇ M., soydan e., ARAT M., TOPÇUOĞLU P., YÜKSEL M., TOPRAK S. K., et al.
XXX. Ulusal Hematoloji Kongresi, Turkey, 10 - 12 October 2003, (Summary Text)

210. Akut Lösemilerde hiperlökositoz olgularında lökaferezin sitoredüksiyon etkinliği

YÜKSEL M., ARAT M., TOPÇUOĞLU P., ayyıldız e., ARSLAN Ö., ÖZCAN M., et al.
XXIX. Ulusal Hematoloji Kongresi, Turkey, 25 October 2002
Metrics

Publication

307

Publication (WoS)

110

Publication (Scopus)

58

Citation (WoS)

1969

H-Index (WoS)

11

Citation (Scopus)

2006

H-Index (Scopus)

13

Citation (Scholar)

173

H-Index (Scholar)

5

Project

2

Thesis Advisory

11

Open Access

24
UN Sustainable Development Goals